Pherecydes Pharma
closedOperator of an innovative biotechnologies company created to develop personalized phage therapy.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Merger | |
| Total Funding | 000k | ||
Omnes Capital(exited)
Fa Diese(exited)
Tikehau Ace Capital(exited)
Auriga Partners(exited)
Participations Besançon(exited)
European Innovation Council(exited)
Elaia Partners(exited)
Karista(exited)
Auriga Partners (Paris)(exited)
PrimaryBid(exited)
GO Capital(exited)
Bpifrance(exited)
PHAXIAM Therapeutics(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Pherecydes Pharma
Editexited